Literature DB >> 23418211

Lifetime physical activity and the risk of amyotrophic lateral sclerosis.

Mark H B Huisman1, Meinie Seelen, Sonja W de Jong, Kirsten R I S Dorresteijn, Perry T C van Doormaal, Anneke J van der Kooi, Marianne de Visser, Helenius Jurgen Schelhaas, Leonard H van den Berg, Jan Herman Veldink.   

Abstract

BACKGROUND: It has been hypothesised that physical activity is a risk factor for developing amyotrophic lateral sclerosis (ALS), fuelled by observations that professional soccer players and Gulf War veterans are at increased risk. In a population based study, we determined the relation between physical activity and risk of sporadic ALS, using an objective approach for assessing physical activity.
METHODS: 636 sporadic ALS patients and 2166 controls, both population based, completed a semistructured questionnaire on lifetime history of occupations, sports and hobbies. To objectively compare the energy cost of a lifetime history of occupational and leisure time physical activities and to reduce recall bias, metabolic equivalent scores were assigned to each activity based on the Compendium of Physical Activities.
RESULTS: ALS patients had significantly higher levels of leisure time physical activity compared with controls (OR 1.08, 95% CI 1.02 to 1.14, p=0.008). No significant difference was found between patients and controls in the level of vigorous physical activities, including marathons and triathlons, or in occupational activity. Cumulative measures of physical activity in quartiles did not show a dose-response relationship.
CONCLUSIONS: An increased risk of ALS with higher levels of leisure time physical activity was found in the present study. The lack of association with occupational physical activity and the absence of a dose-response relationship strengthen the hypothesis that not increased physical activity per se but rather a genetic profile or lifestyle promoting physical fitness increases ALS susceptibility.

Entities:  

Keywords:  ALS; MOTOR NEURON DISEASE

Mesh:

Year:  2013        PMID: 23418211     DOI: 10.1136/jnnp-2012-304724

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  46 in total

1.  Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study.

Authors:  Marianthi-Anna Kioumourtzoglou; Ryan M Seals; Ole Gredal; Murray A Mittleman; Johnni Hansen; Marc G Weisskopf
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-07-20       Impact factor: 4.092

2.  Head injury does not alter disease progression or neuropathologic outcomes in ALS.

Authors:  Christina N Fournier; Marla Gearing; Saila R Upadhyayula; Mitch Klein; Jonathan D Glass
Journal:  Neurology       Date:  2015-04-01       Impact factor: 9.910

Review 3.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

4.  Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies.

Authors:  Éilis J O'Reilly; Molin Wang; Hans-Olov Adami; Alvaro Alonso; Leslie Bernstein; Piet van den Brandt; Julie Buring; Sarah Daugherty; Dennis Deapen; D Michal Freedman; Dallas R English; Graham G Giles; Niclas Håkansson; Tobias Kurth; Catherine Schairer; Elisabete Weiderpass; Alicja Wolk; Stephanie A Smith-Warner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2018-04-16       Impact factor: 4.092

5.  Body mass index delineates ALS from FTD: implications for metabolic health.

Authors:  R M Ahmed; E Mioshi; J Caga; M Shibata; M Zoing; L Bartley; O Piguet; J R Hodges; M C Kiernan
Journal:  J Neurol       Date:  2014-06-24       Impact factor: 4.849

6.  Chronic traumatic encephalopathy: A paradigm in search of evidence?

Authors:  Rudy J Castellani
Journal:  Lab Invest       Date:  2015-04-13       Impact factor: 5.662

7.  Recumbent stepping aerobic exercise in amyotrophic lateral sclerosis: a pilot study.

Authors:  Anjali Sivaramakrishnan; Sangeetha Madhavan
Journal:  Neurol Sci       Date:  2019-02-04       Impact factor: 3.307

Review 8.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

Review 9.  Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Authors:  Björn Oskarsson; D Kevin Horton; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

Review 10.  Effects of exercise on sleep in neurodegenerative disease.

Authors:  Adeel A Memon; Juliana J Coleman; Amy W Amara
Journal:  Neurobiol Dis       Date:  2020-04-01       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.